Page CP et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857401
|
Gresele P et al. |
Platelets and asthma. |
1985 |
Lancet |
pmid:2857402
|
Lenihan DJ et al. |
Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis. |
1985 |
Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. |
pmid:2861063
|
Braquet P et al. |
Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. |
1985 |
Lancet |
pmid:2861423
|
McIntyre TM et al. |
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. |
1985 |
J. Clin. Invest. |
pmid:2862164
|
Archer CB et al. |
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. |
1985 |
Br. J. Pharmacol. |
pmid:2862936
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Malone B et al. |
Inactivation of platelet activating factor by rabbit platelets. Lyso-platelet activating factor as a key intermediate with phosphatidylcholine as the source of arachidonic acid in its conversion to a tetraenoic acylated product. |
1985 |
J. Biol. Chem. |
pmid:3918041
|
Valone FH and Johnson B |
Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1985 |
J. Immunol. |
pmid:2578151
|
Waku K et al. |
Metabolism of 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a precursor of platelet-activating factor in macrophages. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936199
|
Khan SN et al. |
Response to platelet-activating factor of platelets from patients with multiple sclerosis. |
1985 |
Acta Neurol. Scand. |
pmid:3993327
|
Saito K et al. |
Determination of AGEPC generated from human neutrophils and rat skin and muscle tissues by a selected ion monitoring technique of GC/MS. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936200
|
Tamargo J et al. |
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. |
1985 |
Eur. J. Pharmacol. |
pmid:3996472
|
Hanahan DJ et al. |
Platelet-activating factor: a unique lipid chemical mediator. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936201
|
Terashita Z et al. |
Is platelet activating factor (PAF) a mediator of endotoxin shock? |
1985 |
Eur. J. Pharmacol. |
pmid:3996473
|
Inoue K et al. |
Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936203
|
Benveniste J |
Paf-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3159192
|
Verstraete M et al. |
An overview of antiplatelet and antithrombotic drugs. |
1985 |
Haemostasis |
pmid:3159632
|
O'Neill C et al. |
Maternal blood platelet physiology and luteal-phase endocrinology as a means of monitoring pre- and postimplantation embryo viability following in vitro fertilization. |
1985 |
J In Vitro Fert Embryo Transf |
pmid:4020241
|
Heymans F et al. |
Structure-activity relationship in PAF-acether. 2. rac-1-O-Octadecyl-2-O-acetyl-3-O-[gamma-(dimethylamino)propyl]glycerol . |
1985 |
J. Med. Chem. |
pmid:4020830
|
Brain SD and Williams TJ |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. |
1985 |
Br. J. Pharmacol. |
pmid:2416378
|
Touqui L et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. |
1985 |
Biochim. Biophys. Acta |
pmid:3967037
|
Weber N and Benning H |
Ether glycerolipids: novel substrates for studying specificity of enzymes involved in glycerolipid biosynthesis in higher plants. |
1985 |
Eur. J. Biochem. |
pmid:3967662
|
O'Neill C |
Partial characterization of the embryo-derived platelet-activating factor in mice. |
1985 |
J. Reprod. Fertil. |
pmid:4067921
|
Mallet AI and Cunningham FM |
Structural identification of platelet activating factor in psoriatic scale. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970690
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Ardaillou N et al. |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. |
1985 |
Am. J. Physiol. |
pmid:3918460
|
Parente L et al. |
The release of lyso-PAF from guinea-pig lungs. |
1985 |
Eur. J. Pharmacol. |
pmid:4029263
|
Lee TC |
Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes. |
1985 |
J. Biol. Chem. |
pmid:4030776
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone. |
1985 |
J. Med. Chem. |
pmid:4032422
|
Pritchard PH et al. |
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). |
1985 |
Blood |
pmid:4063532
|
Wissner A et al. |
Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group. |
1985 |
J. Med. Chem. |
pmid:4032438
|
Wimberly HC et al. |
Functional and biochemical characterization of immunologically derived equine platelet-activating factor. |
1985 |
Vet. Pathol. |
pmid:4035942
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Surles JR et al. |
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. |
1985 |
J. Med. Chem. |
pmid:4038418
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
Sugiura T et al. |
Transacylation of 1-O-alkyl-SN-glycero-3-phosphocholine (lyso platelet-activating factor) and 1-O-alkenyl-SN-glycero-3-phosphoethanolamine with docosahexaenoic acid (22:6 omega 3). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2935146
|
Hallam TJ et al. |
Relationship between cytoplasmic free calcium and myosin light chain phosphorylation in intact platelets. |
1985 |
Biochem. J. |
pmid:4091795
|
Fouque F and Vargaftig BB |
Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine. |
1985 |
J Pharmacol |
pmid:4094442
|
Oda M et al. |
Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. |
1985 |
J. Immunol. |
pmid:3917470
|
Bergelson LD et al. |
Influence of platelet activation factor and prostaglandins on cholesterol esterification in human plasma. |
1985 |
FEBS Lett. |
pmid:4043408
|
Kilpatrick JM and Virella G |
Inhibition of platelet-activating factor by rabbit C-reactive protein. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:4042435
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Sugiura T and Waku K |
CoA-independent transfer of arachidonic acid from 1,2-diacyl-sn-glycero-3-phosphocholine to 1-O-alkyl-sn-glycero-3-phosphocholine (lyso platelet-activating factor) by macrophage microsomes. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3919727
|
O'Flaherty JT |
Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. |
1985 |
J. Cell. Physiol. |
pmid:2981891
|
Khan SN et al. |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. |
1985 |
Eur. J. Pharmacol. |
pmid:3920056
|
Wasserman SI |
The mast cell and theophylline in asthma. |
1985 |
Am. J. Med. |
pmid:3002176
|
Bushfield M et al. |
Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. |
1985 |
Biochem. J. |
pmid:3002327
|